We are thrilled to congratulate our long-time client LumiThera on receiving
FDA authorization for their groundbreaking Valeda® Light Delivery System,
marking a historic moment as the first-ever authorized treatment for vision
loss in dry age-related macular degeneration (AMD) patients.